Showing results (221-230 of 470) with videos related to
Sort By:
Pageof 47
Mayo Clinic Proceedings|September 7, 2007
A multidisciplinary approach to the management of breast cancer, part 2: therapeutic considerationsSandhya Pruthi, Judy C Boughey, Kathleen R Brandt, et al.Molecular Endocrinology (Baltimore, Md.)|February 12, 2016
Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator RegulationMing-Fen Ho, Tim Bongartz, Mohan Liu, et al.Cancer Chemotherapy and Pharmacology|October 17, 2014
Pharmacokinetics of endoxifen and tamoxifen in female mice: implications for comparative in vivo activity studiesJoel M Reid, Matthew P Goetz, Sarah A Buhrow, et al.BMC Bioinformatics|July 19, 2018
HGT-ID: an efficient and sensitive workflow to detect human-viral insertion sites using next-generation sequencing dataSaurabh Baheti, Xiaojia Tang, Daniel R O'Brien, et al.Pharmacogenomics|October 4, 2011
SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifenAnn M Moyer, Vera J Suman, Richard M Weinshilboum, et al.NPJ Breast Cancer|July 20, 2026
Novel (Z)-endoxifen-related new chemical entities exhibit potent anti-cancer activity in ERα+ breast cancerLena Batoon, Rajeev S Muthyala, Xiyin Wang, et al.The Oncologist|September 22, 2011
Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence scoreArif H Kamal, Charles L Loprinzi, Carol Reynolds, et al.Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|November 22, 2018
Echocardiographic Assessment for the Detection of Cardiotoxicity Due to Vascular Endothelial Growth Factor Inhibitor Therapy in Metastatic Renal Cell and Colorectal CancersLara F Nhola, Sahar S Abdelmoneim, Hector R Villarraga, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)Deirdre R Pachman, Rui Qin, Drew K Seisler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancerDaniel J Sargent, Claus Henning Köhne, Hanna Kelly Sanoff, et al.Pageof 47